Axe Compute Inc. (AGPU) Form 8-K — Sep 17, 2026
$AGPUForm 8-KItems 1.01, 2.01, 9.01Filed Sep 17, 2026, 4:05 PM ET0001171843-26-006093Original filing
Axe Compute Inc. (NASDAQ: AGPU) completed the sale of its wholly owned subsidiary Helomics Corporation to DataMeds AI, Inc. (NASDAQ: MEDS) on September 11, 2026, receiving 636,328 DataMeds shares (19.99% of DataMeds' shares outstanding immediately prior to closing) plus a $1,363,672 convertible promissory note with a $1.00 per-share conversion price. The filing states the sale completes Axe Compute's strategic transition to a pure-play neocloud GPU-as-a-Service company.
Key figures
- Lockup period months
- 12
- Data Meds stake percent
- 19.99%
- Data Meds shares authorized
- 500000000
- Noncompete restriction years
- 3
- Consideration shares data Meds
- 636328
- Convertible note principal usd
- 1363672
- Dno indemnification tail years
- 6
- Helomics shans issued outstanding
- 100
- Convertible note conversion price usd
- 1
- Minimum helomics cash certificate usd
- 1500000
- Data Meds shares outstanding at signing
- 3197633
AI analysis
Red flags5 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.